Showing results (181-190 of 223) with videos related to
Sort By:
Pageof 23
Eclinicalmedicine|May 18, 2023
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trialsPaul E Sax, José R Arribas, Chloe Orkin, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 11, 2018
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort StudySebastiano Leone, Milensu Shanyinde, Alessandro Cozzi Lepri, et al.Pathogens & Immunity|April 18, 2019
Clinical Usefulness of Klebsiella Pneumoniae Carbapenemase-Producing K. Pneumoniae Genotyping: The Experience of a Single-Center EpidemicMarianna Rossi, Liliane Chatenoud, Egidio Franco Viganò, et al.Journal of Hepatology|August 4, 2004
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patientsMassimo Puoti, Barbara Zanini, Gian Paolo Quinzan, et al.Plos One|April 25, 2014
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter studyDaria Gotti, Elena Raffetti, Laura Albini, et al.Infectious Diseases and Therapy|March 9, 2021
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label TrialFranco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina, et al.HIV Medicine|May 9, 2022
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of ageFranco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina, et al.The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.World Journal of Hepatology|May 23, 2019
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysisGiovanni Damiani, Sebastiano Leone, Kristen Fajgenbaum, et al.Open Forum Infectious Diseases|July 7, 2018
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort StudyRoberta Gagliardini, Arturo Ciccullo, Alberto Borghetti, et al.Pageof 23